Similar articles

• Rationale and use of vasodilators in the management of congestive heart failure.

  Lakier JB, Khaja F, Stein PD. Lakier JB, et al. Am Heart J. 1979 Apr;97(4):519-26. doi: 10.1016/0002-8703(79)90402-2. Am Heart J. 1979. PMID: 371379 Review. No abstract available.
• Vasodilator therapy for decompensated heart failure.

  Yancy CW. Yancy CW. J Am Coll Cardiol. 2008 Jul 15;52(3):208-10. doi: 10.1016/j.jacc.2008.03.046. J Am Coll Cardiol. 2008. PMID: 18617069 No abstract available.
• Recent advances in vasodilator therapy. Part I: physiologic correlations.

  Aranda JM, Linares E, Hernández-López E, Cintrón G, Song S. Aranda JM, et al. Bol Asoc Med P R. 1981 Jan;73(1):3-10. Bol Asoc Med P R. 1981. PMID: 7020713 Review. No abstract available.
• Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective.

  Mason DT. Mason DT. Am J Med. 1978 Jul;65(1):101-5. doi: 10.1016/0002-9343(78)90699-x. Am J Med. 1978. PMID: 356597 Review. No abstract available.
• Vasodilator therapy for congestive heart failure.

  Fouad FM. Fouad FM. Cardiovasc Clin. 1981;12(2):127-35. Cardiovasc Clin. 1981. PMID: 7344769 No abstract available.